In this article, we are going to take a look at where Elevance Health ... as per Insider Monkey's database of Q4 2024. From less preferred to highly preferred, according to hedge funds, the ...

Artisan Select Equity Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “Elevance Health, Inc. (NYSE:ELV) took a couple of blows this quarter.

Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Elevance Health, Inc.

On July 17, 2024, Elevance disclosed that it was "expecting second-half utilization to increase in Medicaid" and that it was "seeing signs of increased utilization across the broader Medicaid ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE ... D1 Capital's public portfolio returned 44% in 2024, driven by strategic investments in European stocks.

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other cheap ESG stocks. These days, it seems like everyone wants to wear the “saving the ...

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

Days after Elevance Health assured investors it remains optimistic about Medicare Advantage, the health insurance company announced it will stop marketing most products under the program.

Leerink Partnrs also issued estimates for Elevance Health’s Q4 2025 earnings at $4.03 EPS, FY2025 earnings at $34.37 EPS, Q3 2026 earnings at $9.87 EPS, Q4 2026 earnings at $5.03 EPS ...